Pressure Grows on U.S. Companies to Share Covid Vaccine Technology

Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company to license its technology.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Public-Private Sector Cooperation Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Factories and Manufacturing Intellectual Property Moderna Inc Pfizer Inc Biden, Joseph R Jr Africa Source Type: news